Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion

Adelaide Ij Young1, Paul Timpson1,2, David Gallego-Ortega1,2

  • 1a Cancer Research Division , Garvan Institute of Medical Research and the Kinghorn Cancer Centre , 384 Victoria Street, Darlinghurst , NSW , Australia.

Cell Adhesion & Migration
|November 24, 2017
PubMed

Insights

Myeloid cell leukemia-1 (MCL-1) protein regulates cancer cell survival and invasion. Inhibiting MCL-1 suppressed breast cancer progression by affecting cytoskeletal remodeling and protein kinase signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Myeloid cell leukemia-1 (MCL-1) is a key regulator of cell survival, closely related to BCL-2.
  • MCL-1 is an emerging therapeutic target for various cancers, including breast cancer.

Purpose of the Study:

  • To investigate the role of MCL-1 in breast cancer progression beyond cell survival.
  • To elucidate the mechanisms by which MCL-1 modulates cellular invasion.

Main Methods:

  • Utilized a MCL-1-specific genetic antagonist in pre-clinical breast cancer models.
  • Analyzed MCL-1's direct binding and phosphorylation effects on Cofilin.
  • Assessed the impact of MCL-1 on SRC family kinases (SFKs) and their downstream targets.

Main Results:

  • Inhibition of MCL-1 effectively suppressed tumor progression in breast cancer models.
  • MCL-1 directly interacts with and alters Cofilin phosphorylation, impacting cytoskeletal remodeling during invasion.
  • MCL-1 modulates SRC family kinases (SFKs) signaling pathways involved in cellular invasion.

Conclusions:

  • MCL-1's functions extend beyond cell survival to directly influence protein kinase signaling during cancer cell invasion.
  • Targeting MCL-1 offers a promising therapeutic strategy for breast cancer by impacting both survival and invasion mechanisms.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K